CHGB · Partner-reported service scope
Genetic Health Risk Assessment
Polygenic and monogenic risk assessment across cancer, endocrine, autoimmune, cardiovascular and age-related disease, with integrated genetic counselling.
- Partner-reported scope
- 200+ risk projects
CHGB · Partner-reported
Service capabilities
The following scope is reported by the partner. Quantities describe the partner portfolio and do not represent VectorGene’s own track record.
- Common cancer risk
- 20+ types.
- Endocrine and metabolic
- Type II diabetes, insulin resistance, hyperlipidaemia.
- Autoimmune
- Rheumatoid arthritis, systemic lupus erythematosus.
- Cardiovascular and cerebrovascular
- Hypertension, atrial fibrillation, atherosclerosis, coronary heart disease, stroke.
- Age-related
- Alzheimer's disease, Parkinson's disease.
- Pharmacogenomics
- P450, folate metabolism, vitamin D and calcium sensitivity.
Explore services in this category.
Read each service’s complete scope and regulatory note. These links help you explore the portfolio; programme-specific suitability requires feasibility assessment.
Risk information needs context and counselling.
A genetic risk service should explain which conditions and variant types it assesses, who it is intended for and how results will be discussed. The programme brief should make room for family context, uncertainty and further assessment rather than frame genetic findings as an exact prediction of future health.
Genetic results are interpreted alongside the test’s purpose and personal and family history. A negative result can leave questions unresolved, and an uncertain variant does not establish or exclude a diagnosis.
MedlinePlus Genetics: What do the results of genetic tests mean?External references explain the wider context. They do not verify or endorse the supplied VectorGene or partner offering.
Questions for the programme brief
Which conditions and population?
Request the gene or score scope, intended population and evidence relevant to that population.
What does the result mean?
Review absolute or relative risk reporting, limitations, uncertain variants and what a negative result can establish.
How will people receive support?
Agree counselling, family implications, referral and the process for updating information when evidence changes.
What to prepare for review
- Risk-model or gene-panel specification
- Population-specific evidence
- Counselling and reporting framework
Working environments
Clinical context. Careful review.
Illustrative stock photography provides context for the people, processes and working environments behind this capability.
